Monash IVF Group Limited

ASX MVF.AX

Monash IVF Group Limited Price to Sales Ratio (P/S) on January 14, 2025: 1.72

Monash IVF Group Limited Price to Sales Ratio (P/S) is 1.72 on January 14, 2025, a -27.92% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

Monash IVF Group Limited 52-week high Price to Sales Ratio (P/S) is 2.74 on May 07, 2024, which is 59.45% above the current Price to Sales Ratio (P/S).
Monash IVF Group Limited 52-week low Price to Sales Ratio (P/S) is 1.65 on November 17, 2024, which is -3.71% below the current Price to Sales Ratio (P/S).
Monash IVF Group Limited average Price to Sales Ratio (P/S) for the last 52 weeks is 2.16.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

ASX: MVF.AX

Monash IVF Group Limited

CEO	Mr. Michael D. Knaap
IPO Date	June 26, 2014
Location	Australia
Headquarters	Pelaco Building 1
Employees	997
Sector	Health Care
Industries Hospitals & Clinics Engineering Services Professional Services

Description

Monash IVF Group Limited provides assisted reproductive and specialist women imaging services in Australia and Malaysia. The company offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. It also provides tertiary level prenatal diagnostic and IVF treatment services. The company was incorporated in 2014 and is based in Richmond, Australia.

Key trends

Past 5 years